Fenny Lin
Family · West Covina, CANPI 1609237155
Payments from drug & device makers
Across 104 payments — averaging $32.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$645
- Kowa Pharmaceuticals America, Inc.$631
- Gilead$535
- Novo Nordisk$295
- Biohaven Pharmaceuticals, Inc.$251
- Boehringer Ingelheim$180
- plus $828 from 13 others
What the payments were for
- Food & beverage$3,365100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 17 | $645 |
| Kowa Pharmaceuticals America, Inc. | 23 | $631 |
| Gilead | 20 | $535 |
| Novo Nordisk | 7 | $295 |
| Biohaven Pharmaceuticals, Inc. | 5 | $251 |
| Boehringer Ingelheim | 5 | $180 |
| Exact Sciences | 4 | $144 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $132 |
| AstraZeneca | 1 | $125 |
| Bayer | 3 | $104 |
| Corcept Therapeutics | 4 | $83 |
| AbbVie | 3 | $81 |
| Pfizer | 2 | $45 |
| Amarin Pharma, Inc. | 2 | $33 |
| Ultragenyx Pharmaceutical Inc. | 1 | $24 |
| Merck | 1 | $21 |
| Sanofi Pasteur Inc. | 1 | $19 |
| GSK | 1 | $12 |
| Genentech USA, Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,365 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 48 | $74,714 |
| EliquisApixaban | 42 | $40,280 |
| MounjaroTirzepatide | 28 | $27,170 |
| JanuviaSitagliptin Phosphate | 22 | $20,761 |
| VemlidyTenofovir Alafenamide | 14 | $19,578 |
| VascepaIcosapent Ethyl | 25 | $18,946 |
| OzempicSemaglutide | 21 | $18,498 |
| EntrestoSacubitril/Valsartan | 16 | $15,005 |
| TrulicityDulaglutide | 14 | $14,005 |
| XiidraLifitegrast | 11 | $7,743 |
| Atorvastatin Calcium | 156 | $1,505 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 54 | $1,158 |
| Ranolazine ErRanolazine | 13 | $1,104 |
| Diclofenac Sodium | 25 | $717 |
| Losartan Potassium | 74 | $661 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $180 | $74,71448 claims |
| Lilly USA, LLCMounjaro, Trulicity | $645 | $41,17542 claims |
| PfizerEliquis | $45 | $40,28042 claims |
| MerckJanuvia | $21 | $20,76122 claims |
| GileadVemlidy | $535 | $19,57814 claims |
| Novo NordiskOzempic | $295 | $18,49821 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,634 family providers in California.
Other family in West Covina
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Nancy GardettoSan Diego$394K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Jenine StoneEscondido$231K
- Erin DwyerSan Diego$189K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.